Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Inovio Pharma (INO)

Inovio Pharma (INO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.6100 +0.0300 (+1.90%) 04/11/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.6000 -0.0100 (-0.62%) 17:50 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.5597
Day High
1.6250
Open 1.5800
Previous Close 1.5800 1.5800
Volume 679,700 679,700
Avg Vol 870,535 870,535
Stochastic %K 32.81% 32.81%
Weighted Alpha -79.75 -79.75
5-Day Change +0.0500 (+3.21%) +0.0500 (+3.21%)
52-Week Range 1.4200 - 13.4400 1.4200 - 13.4400
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 59,034
  • Shares Outstanding, K 36,667
  • Annual Sales, $ 220 K
  • Annual Income, $ -107,250 K
  • EBIT $ -112 M
  • EBITDA $ -109 M
  • 60-Month Beta 1.84
  • Price/Sales 265.75
  • Price/Cash Flow N/A
  • Price/Book 0.83

Options Overview Details

View History
  • Implied Volatility 340.81% ( -244.02%)
  • Historical Volatility 72.70%
  • IV Percentile 93%
  • IV Rank 43.12%
  • IV High 765.89% on 04/04/25
  • IV Low 18.57% on 08/26/24
  • Put/Call Vol Ratio 0.17
  • Today's Volume 342
  • Volume Avg (30-Day) 205
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 13,139
  • Open Int (30-Day) 12,926

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.74
  • Number of Estimates 2
  • High Estimate -0.73
  • Low Estimate -0.75
  • Prior Year -1.31
  • Growth Rate Est. (year over year) +43.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4200 +13.38%
on 04/09/25
Period Open: 1.9500
2.1800 -26.15%
on 03/17/25
-0.3400 (-17.44%)
since 03/11/25
3-Month
1.4200 +13.38%
on 04/09/25
Period Open: 1.9800
2.3350 -31.05%
on 01/27/25
-0.3700 (-18.69%)
since 01/10/25
52-Week
1.4200 +13.38%
on 04/09/25
Period Open: 11.7600
13.4400 -88.02%
on 05/16/24
-10.1500 (-86.31%)
since 04/11/24

Most Recent Stories

More News
Inovio Pharmaceuticals (INO) Q4 2024 Earnings Call Transcript

INO earnings call for the period ending December 31, 2024.

INO : 1.6100 (+1.90%)
PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally?

Shares of Precigen PGEN have soared nearly 43% in the past week after the company provided an encouraging regulatory update for its lead pipeline program.Last week, Precigen announced that it has completed...

CTMX : 0.5325 (+7.66%)
PGEN : 1.4000 (+9.38%)
CSTL : 19.70 (+2.07%)
INO : 1.6100 (+1.90%)
Inovio Pharmaceuticals Q3 Earnings Tops Estimates, Lifts Retail Sentiment

For the quarter ending September 30, Inovio reported a loss of $0.89 per share, beating analyst estimates of a $1.15 loss per share, according to Stocktwits data.

VXF : 160.66 (+1.55%)
VTI : 261.74 (+1.67%)
INO : 1.6100 (+1.90%)
IWM : 184.36 (+1.46%)
Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript

INO earnings call for the period ending September 30, 2024.

INO : 1.6100 (+1.90%)
Inovio Pharma Stock Slips Ahead of Q3 Earnings: Retail’s Bullish

Retail sentiment on the stock dipped to ‘bullish’ from ‘extremely bullish’ last week.

VXF : 160.66 (+1.55%)
VTI : 261.74 (+1.67%)
INO : 1.6100 (+1.90%)
IWM : 184.36 (+1.46%)
Inovio: Q3 Earnings Snapshot

Inovio: Q3 Earnings Snapshot

INO : 1.6100 (+1.90%)
Will Trump 2.0 Nurse Biotechs Back To Health: 10 Stocks Retail Is Watching

Less stringent requirements in pharmaceuticals and biotechnology could help biotechs by prompting accelerated drug approvals.

SRNE : 0.0010 (+11.11%)
TNXP : 16.88 (-2.43%)
IBB : 116.96 (+3.38%)
JAGX : 5.57 (+8.79%)
NVAX : 5.86 (+7.92%)
INO : 1.6100 (+1.90%)
GILD : 103.63 (+2.20%)
MRNA : 26.20 (+6.94%)
VXRT : 0.3562 (+13.30%)
IBIO : 1.2000 (-0.83%)
XBI : 74.33 (+3.80%)
PFE : 21.91 (+1.48%)
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NYSE:PFE),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

SBFM : 1.3600 (-1.45%)
MRNA : 26.20 (+6.94%)
PFE : 21.91 (+1.48%)
INO : 1.6100 (+1.90%)
VIR : 5.53 (+4.73%)
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

SBFM : 1.3600 (-1.45%)
MRNA : 26.20 (+6.94%)
PFE : 21.91 (+1.48%)
INO : 1.6100 (+1.90%)
VIR : 5.53 (+4.73%)
Inovio Pharmaceuticals (INO) Q2 2024 Earnings Call Transcript

INO earnings call for the period ending June 30, 2024.

INO : 1.6100 (+1.90%)
CVR: Q3 Earnings Snapshot

CVR: Q3 Earnings Snapshot

CVI : 17.66 (+5.18%)
CVR Energy Reports Third Quarter 2024 Results

CVI : 17.66 (+5.18%)
CVR Energy to Release Third Quarter 2024 Earnings Results

CVI : 17.66 (+5.18%)
Elliott Investment Managment Wins $7 Billion Auction for Citgo Shares

Elliott Investment Management has emerged as the presumptive winner in the auction for shares in PDV Holding, the parent company of Citgo Petroleum. The winning bid, valued at up to $7.286 billion, includes...

MPC : 123.43 (+1.56%)
PSX : 97.38 (+0.40%)
CVI : 17.66 (+5.18%)
CVR: Q2 Earnings Snapshot

CVR: Q2 Earnings Snapshot

CVI : 17.66 (+5.18%)
This Dividend Stock Is Carl Icahn's Biggest Bet. Should You Buy It?

Carl Icahn's Icahn Enterprises owns 15% of Southwest Gas. Is that enough to make it worth adding to your portfolio?

ILMN : 74.78 (+4.94%)
SWX : 71.09 (+2.26%)
IEP : 8.21 (+2.24%)
CVI : 17.66 (+5.18%)
CVR: Q1 Earnings Snapshot

CVR: Q1 Earnings Snapshot

CVI : 17.66 (+5.18%)
More Than a Quarter of Billionaire Carl Icahn's Portfolio Is In These 3 Energy Stocks

Legendary investor Carl Icahn is betting big on several oil and gas stocks.

VLO : 110.70 (+1.55%)
CVI : 17.66 (+5.18%)
OXY : 37.67 (+3.29%)
SWX : 71.09 (+2.26%)
Billionaire Carl Icahn Has a Whopping 62% of His Portfolio in 1 Stock

You can invest along with Carl Icahn with this stock.

IEP : 8.21 (+2.24%)
AAPL : 198.15 (+4.06%)
OXY : 37.67 (+3.29%)
CVI : 17.66 (+5.18%)
SWX : 71.09 (+2.26%)
Icahn Enterprises: Buy, Sell, or Hold?

Icahn Enterprises stock is battling several difficult challenges. Will it succeed?

BRK.AX : 0.360 (-4.00%)
CVI : 17.66 (+5.18%)
IEP : 8.21 (+2.24%)
CVR: Q3 Earnings Snapshot

CVR: Q3 Earnings Snapshot

CVI : 17.66 (+5.18%)
CVR Energy Reports Third Quarter 2024 Results

CVI : 17.66 (+5.18%)
CVR Energy to Release Third Quarter 2024 Earnings Results

CVI : 17.66 (+5.18%)
Elliott Investment Managment Wins $7 Billion Auction for Citgo Shares

Elliott Investment Management has emerged as the presumptive winner in the auction for shares in PDV Holding, the parent company of Citgo Petroleum. The winning bid, valued at up to $7.286 billion, includes...

MPC : 123.43 (+1.56%)
PSX : 97.38 (+0.40%)
CVI : 17.66 (+5.18%)
CVR: Q2 Earnings Snapshot

CVR: Q2 Earnings Snapshot

CVI : 17.66 (+5.18%)
This Dividend Stock Is Carl Icahn's Biggest Bet. Should You Buy It?

Carl Icahn's Icahn Enterprises owns 15% of Southwest Gas. Is that enough to make it worth adding to your portfolio?

ILMN : 74.78 (+4.94%)
SWX : 71.09 (+2.26%)
IEP : 8.21 (+2.24%)
CVI : 17.66 (+5.18%)
CVR: Q1 Earnings Snapshot

CVR: Q1 Earnings Snapshot

CVI : 17.66 (+5.18%)
More Than a Quarter of Billionaire Carl Icahn's Portfolio Is In These 3 Energy Stocks

Legendary investor Carl Icahn is betting big on several oil and gas stocks.

VLO : 110.70 (+1.55%)
CVI : 17.66 (+5.18%)
OXY : 37.67 (+3.29%)
SWX : 71.09 (+2.26%)
Billionaire Carl Icahn Has a Whopping 62% of His Portfolio in 1 Stock

You can invest along with Carl Icahn with this stock.

IEP : 8.21 (+2.24%)
AAPL : 198.15 (+4.06%)
OXY : 37.67 (+3.29%)
CVI : 17.66 (+5.18%)
SWX : 71.09 (+2.26%)
Icahn Enterprises: Buy, Sell, or Hold?

Icahn Enterprises stock is battling several difficult challenges. Will it succeed?

BRK.AX : 0.360 (-4.00%)
CVI : 17.66 (+5.18%)
IEP : 8.21 (+2.24%)

Business Summary

Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled...

See More

Key Turning Points

3rd Resistance Point 1.7021
2nd Resistance Point 1.6635
1st Resistance Point 1.6368
Last Price 1.6100
1st Support Level 1.5715
2nd Support Level 1.5329
3rd Support Level 1.5062

See More

52-Week High 13.4400
Fibonacci 61.8% 8.8484
Fibonacci 50% 7.4300
Fibonacci 38.2% 6.0116
Last Price 1.6100
52-Week Low 1.4200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar